z-logo
open-access-imgOpen Access
Tofacitinib, two‐faced Janus in ulcerative colitis and Crohn’s disease?
Author(s) -
Biemans Vince BC,
Verstockt Bram
Publication year - 2020
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640620942641
Subject(s) - tofacitinib , medicine , ulcerative colitis , infliximab , ustekinumab , janus kinase inhibitor , inflammatory bowel disease , janus kinase , adverse effect , pharmacology , rheumatoid arthritis , disease , cytokine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom